Astellas Pharma Singapore Pte. Ltd.
9 clinical trials · Sponsor
◉ Watch Astellas Pharma Singapore Pte. Ltd.
| Record | Firm | Date |
|---|---|---|
| Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant (NCT06734585) | Astellas Pharma Singapore Pte. Ltd. | 2025-01-09 |
| A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia (NCT06505746) | Astellas Pharma Singapore Pte. Ltd. | 2024-08-29 |
| A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS) (NCT04553029) | Astellas Pharma Singapore Pte. Ltd. | 2020-09-09 |
| Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania (NCT03602508) | Astellas Pharma Singapore Pte. Ltd. | 2018-07-20 |
| A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China (NCT03572231) | Astellas Pharma Singapore Pte. Ltd. | 2018-07-19 |
Track Astellas Pharma Singapore Pte. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.